首页 > 最新文献

Expert review of medical devices最新文献

英文 中文
Single-pulse transcranial magnetic stimulation for assessment of motor development in infants with early brain injury. 单脉冲经颅磁刺激用于评估早期脑损伤婴儿的运动发育。
Pub Date : 2024-03-01 Epub Date: 2024-01-03 DOI: 10.1080/17434440.2023.2299310
Ellen N Sutter, Cameron P Casey, Bernadette T Gillick

Introduction: Single-pulse transcranial magnetic stimulation (TMS) has many applications for pediatric clinical populations, including infants with perinatal brain injury. As a noninvasive neuromodulation tool, single-pulse TMS has been used safely in infants and children to assess corticospinal integrity and circuitry patterns. TMS may have important applications in early detection of atypical motor development or cerebral palsy.

Areas covered: The authors identified and summarized relevant studies incorporating TMS in infants, including findings related to corticospinal development and circuitry, motor cortex localization and mapping, and safety. This special report also describes methodologies and safety considerations related to TMS assessment in infants, and discusses potential applications related to diagnosis of cerebral palsy and early intervention.

Expert opinion: Single-pulse TMS has demonstrated safety and feasibility in infants with perinatal brain injury and may provide insight into neuromotor development and potential cerebral palsy diagnosis. Additional research in larger sample sizes will more fully evaluate the utility of TMS biomarkers in early diagnosis and intervention. Methodological challenges to performing TMS in infants and technical/equipment limitations require additional consideration and innovation toward clinical implementation. Future research may explore use of noninvasive neuromodulation techniques as an intervention in younger children with perinatal brain injury to improve motor outcomes.

简介:单脉冲经颅磁刺激(TMS)在儿科临床人群中有很多应用,包括围产期脑损伤婴儿。作为一种无创神经调节工具,单脉冲经颅磁刺激已被安全地用于婴幼儿,以评估皮质脊髓的完整性和电路模式。TMS 在早期检测不典型运动发育或脑瘫方面可能有重要应用:作者确定并总结了对婴儿进行 TMS 的相关研究,包括与皮质脊髓发育和电路、运动皮层定位和映射以及安全性相关的研究结果。本特别报告还介绍了与婴儿 TMS 评估相关的方法和安全注意事项,并讨论了与脑瘫诊断和早期干预相关的潜在应用:单脉冲经颅磁刺激已在围产期脑损伤婴儿中证明了其安全性和可行性,并可为神经运动发育和潜在的脑瘫诊断提供洞察力。对更大样本量的其他研究将更全面地评估TMS生物标志物在早期诊断和干预中的效用。在婴儿中进行 TMS 所面临的方法学挑战和技术/设备限制需要更多的考虑和创新,以实现临床应用。未来的研究可能会探索使用非侵入性神经调控技术作为围产期脑损伤低龄儿童的干预措施,以改善运动效果。
{"title":"Single-pulse transcranial magnetic stimulation for assessment of motor development in infants with early brain injury.","authors":"Ellen N Sutter, Cameron P Casey, Bernadette T Gillick","doi":"10.1080/17434440.2023.2299310","DOIUrl":"10.1080/17434440.2023.2299310","url":null,"abstract":"<p><strong>Introduction: </strong>Single-pulse transcranial magnetic stimulation (TMS) has many applications for pediatric clinical populations, including infants with perinatal brain injury. As a noninvasive neuromodulation tool, single-pulse TMS has been used safely in infants and children to assess corticospinal integrity and circuitry patterns. TMS may have important applications in early detection of atypical motor development or cerebral palsy.</p><p><strong>Areas covered: </strong>The authors identified and summarized relevant studies incorporating TMS in infants, including findings related to corticospinal development and circuitry, motor cortex localization and mapping, and safety. This special report also describes methodologies and safety considerations related to TMS assessment in infants, and discusses potential applications related to diagnosis of cerebral palsy and early intervention.</p><p><strong>Expert opinion: </strong>Single-pulse TMS has demonstrated safety and feasibility in infants with perinatal brain injury and may provide insight into neuromotor development and potential cerebral palsy diagnosis. Additional research in larger sample sizes will more fully evaluate the utility of TMS biomarkers in early diagnosis and intervention. Methodological challenges to performing TMS in infants and technical/equipment limitations require additional consideration and innovation toward clinical implementation. Future research may explore use of noninvasive neuromodulation techniques as an intervention in younger children with perinatal brain injury to improve motor outcomes.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10947901/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139081178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hydrophilic biomaterial intravenous hydrogel catheter for complication reduction in PICC and midline catheters. 用于减少 PICC 和中线导管并发症的亲水性生物材料静脉注射水凝胶导管。
Pub Date : 2024-03-01 Epub Date: 2024-03-06 DOI: 10.1080/17434440.2024.2324885
Nancy Moureau

Introduction: More than 30% of peripherally inserted central catheters (PICCs) and midline catheters experience complications. Most complications are related to thrombotic cellular adherence to catheter materials.

Areas covered: This manuscript outlines PICC and midline catheter complications, the need to reduce complications and how hydrogel catheters may provide a solution to address these unmet needs based on available evidence.

Expert opinion: Patients commonly require PICC or midline catheters for treatment to establish a reliable form of intravenous access. Catheters, while reliable in most cases, are not without complications, including occlusion, thrombosis and infection, each related to cellular adherence to the catheter material. Hydrophilic catheter coatings and composites have been developed to mitigate these thrombotic complications, reduce adherence of blood and bacterial cells to catheters and provide greater patient safety with these devices. Hydrogel materials are highly biocompatible and have been effective in reducing cellular adherence and the formation of biofilms on surfaces. Smooth hydrophilic catheter surfaces are potentially more comfortable for the patient, with reduced friction during insertion and removal. A catheter constructed of hydrophilic biomaterial, a hydrogel composite material, may minimize thrombotic complications in PICC and midline catheters, improving catheter performance and outcomes for patients.

导言:30%以上的外周置入中心导管(PICC)和中线导管会出现并发症。大多数并发症与导管材料上的血栓细胞粘附有关:本手稿概述了 PICC 和中线导管并发症、减少并发症的必要性以及水凝胶导管如何根据现有证据为满足这些未满足的需求提供解决方案:患者通常需要使用 PICC 或中线导管进行治疗,以建立可靠的静脉通路。导管虽然在大多数情况下都很可靠,但也并非没有并发症,包括闭塞、血栓形成和感染,每种并发症都与导管材料上的细胞粘附有关。目前已开发出亲水性导管涂层和复合材料,以减轻这些血栓形成并发症,减少血液和细菌细胞对导管的粘附,并提高这些设备对患者的安全性。水凝胶材料具有很高的生物相容性,能有效减少细胞附着和表面生物膜的形成。光滑的亲水性导管表面可以减少插入和拔出导管时的摩擦,从而让患者感觉更舒适。由亲水性生物材料(一种水凝胶复合材料)制成的导管可最大程度地减少 PICC 和中线导管的血栓并发症,从而改善导管的性能和患者的治疗效果。
{"title":"Hydrophilic biomaterial intravenous hydrogel catheter for complication reduction in PICC and midline catheters.","authors":"Nancy Moureau","doi":"10.1080/17434440.2024.2324885","DOIUrl":"10.1080/17434440.2024.2324885","url":null,"abstract":"<p><strong>Introduction: </strong>More than 30% of peripherally inserted central catheters (PICCs) and midline catheters experience complications. Most complications are related to thrombotic cellular adherence to catheter materials.</p><p><strong>Areas covered: </strong>This manuscript outlines PICC and midline catheter complications, the need to reduce complications and how hydrogel catheters may provide a solution to address these unmet needs based on available evidence.</p><p><strong>Expert opinion: </strong>Patients commonly require PICC or midline catheters for treatment to establish a reliable form of intravenous access. Catheters, while reliable in most cases, are not without complications, including occlusion, thrombosis and infection, each related to cellular adherence to the catheter material. Hydrophilic catheter coatings and composites have been developed to mitigate these thrombotic complications, reduce adherence of blood and bacterial cells to catheters and provide greater patient safety with these devices. Hydrogel materials are highly biocompatible and have been effective in reducing cellular adherence and the formation of biofilms on surfaces. Smooth hydrophilic catheter surfaces are potentially more comfortable for the patient, with reduced friction during insertion and removal. A catheter constructed of hydrophilic biomaterial, a hydrogel composite material, may minimize thrombotic complications in PICC and midline catheters, improving catheter performance and outcomes for patients.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140041185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Towards an evaluation framework for medical device-integrated electronic medical record. 医疗设备集成电子病历的评估框架。
Pub Date : 2024-03-01 Epub Date: 2024-02-13 DOI: 10.1080/17434440.2024.2315024
Aeshah Alhammad, Maryati Mohd Yusof, Dian Indrayani Jambari

Introduction: Medical device (MD)-integrated (I) electronic medical record (EMR) (MDI-EMR) poses cyber threats that undermine patient safety, and thus, they require effective control mechanisms. We reviewed the related literature, including existing EMR and MD risk assessment approaches, to identify MDI-EMR comprehensive evaluation dimensions and measures.

Areas covered: We searched multiple databases, including PubMed, Web of Knowledge, Scopus, ACM, Embase, IEEE and Ingenta. We explored various evaluation aspects of MD and EMR to gain a better understanding of their complex integration. We reviewed numerous risk management and assessment frameworks related to MD and EMR security aspects and mitigation controls and then identified their common evaluation aspects. Our review indicated that previous evaluation frameworks assessed MD and EMR independently. To address this gap, we proposed an evaluation framework based on the sociotechnical dimensions of health information systems and risk assessment approaches for MDs to evaluate MDI-EMR integratively.

Expert opinion: The emergence of MDI-EMR cyber threats requires appropriate evaluation tools to ensure the safe development and application of MDI-EMR. Consequently, our proposed framework will continue to evolve through subsequent validations and refinements. This process aims to establish its applicability in informing stakeholders of the safety level and assessing its effectiveness in mitigating risks for future improvements.

导言:医疗设备(MD)-集成(I)电子病历(EMR)(MDI-EMR)构成了破坏患者安全的网络威胁,因此需要有效的控制机制。我们查阅了相关文献,包括现有的 EMR 和 MD 风险评估方法,以确定 MDI-EMR 的综合评估维度和措施:我们检索了多个数据库,包括 PubMed、Web of Knowledge、Scopus、ACM、Embase、IEEE 和 Ingenta。我们探讨了 MD 和 EMR 的各种评估方面,以更好地了解它们之间复杂的整合。我们审查了与 MD 和 EMR 安全方面和缓解控制有关的众多风险管理和评估框架,然后确定了它们的共同评估方面。我们的审查表明,以前的评估框架是独立评估 MD 和 EMR 的。为了弥补这一不足,我们提出了一个基于医疗信息系统社会技术维度和 MD 风险评估方法的评估框架,以综合评估 MDI-EMR:MDI-EMR 网络威胁的出现需要适当的评估工具,以确保 MDI-EMR 的安全开发和应用。因此,我们提出的框架将通过后续的验证和完善继续发展。这一过程旨在确定其在告知利益相关者安全级别方面的适用性,并评估其在降低风险方面的有效性,以便在未来进行改进。
{"title":"Towards an evaluation framework for medical device-integrated electronic medical record.","authors":"Aeshah Alhammad, Maryati Mohd Yusof, Dian Indrayani Jambari","doi":"10.1080/17434440.2024.2315024","DOIUrl":"10.1080/17434440.2024.2315024","url":null,"abstract":"<p><strong>Introduction: </strong>Medical device (MD)-integrated (I) electronic medical record (EMR) (MDI-EMR) poses cyber threats that undermine patient safety, and thus, they require effective control mechanisms. We reviewed the related literature, including existing EMR and MD risk assessment approaches, to identify MDI-EMR comprehensive evaluation dimensions and measures.</p><p><strong>Areas covered: </strong>We searched multiple databases, including PubMed, Web of Knowledge, Scopus, ACM, Embase, IEEE and Ingenta. We explored various evaluation aspects of MD and EMR to gain a better understanding of their complex integration. We reviewed numerous risk management and assessment frameworks related to MD and EMR security aspects and mitigation controls and then identified their common evaluation aspects. Our review indicated that previous evaluation frameworks assessed MD and EMR independently. To address this gap, we proposed an evaluation framework based on the sociotechnical dimensions of health information systems and risk assessment approaches for MDs to evaluate MDI-EMR integratively.</p><p><strong>Expert opinion: </strong>The emergence of MDI-EMR cyber threats requires appropriate evaluation tools to ensure the safe development and application of MDI-EMR. Consequently, our proposed framework will continue to evolve through subsequent validations and refinements. This process aims to establish its applicability in informing stakeholders of the safety level and assessing its effectiveness in mitigating risks for future improvements.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139693719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction. 更正。
Pub Date : 2024-01-10 DOI: 10.1080/17434440.2023.2300226
{"title":"Correction.","authors":"","doi":"10.1080/17434440.2023.2300226","DOIUrl":"https://doi.org/10.1080/17434440.2023.2300226","url":null,"abstract":"","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139418842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wearable devices for gait and posture monitoring via telemedicine in people with movement disorders and multiple sclerosis: a systematic review. 通过远程医疗监测运动障碍和多发性硬化症患者步态和姿势的可穿戴设备:系统综述。
Pub Date : 2024-01-01 Epub Date: 2024-02-04 DOI: 10.1080/17434440.2023.2298342
Francesca Salaorni, Giulia Bonardi, Federico Schena, Michele Tinazzi, Marialuisa Gandolfi

Introduction: Wearable devices and telemedicine are increasingly used to track health-related parameters across patient populations. Since gait and postural control deficits contribute to mobility deficits in persons with movement disorders and multiple sclerosis, we thought it interesting to evaluate devices in telemedicine for gait and posture monitoring in such patients.

Methods: For this systematic review, we searched the electronic databases MEDLINE (PubMed), SCOPUS, Cochrane Library, and SPORTDiscus. Of the 452 records retrieved, 12 met the inclusion/exclusion criteria. Data about (1) study characteristics and clinical aspects, (2) technical, and (3) telemonitoring and teleconsulting were retrieved, The studies were quality assessed.

Results: All studies involved patients with Parkinson's disease; most used triaxial accelerometers for general assessment (n = 4), assessment of motor fluctuation (n = 3), falls (n = 2), and turning (n = 3). Sensor placement and count varied widely across studies. Nine used lab-validated algorithms for data analysis. Only one discussed synchronous patient feedback and asynchronous teleconsultation.

Conclusions: Wearable devices enable real-world patient monitoring and suggest biomarkers for symptoms and behaviors related to underlying gait disorders. thus enriching clinical assessment and personalized treatment plans. As digital healthcare evolves, further research is needed to enhance device accuracy, assess user acceptability, and integrate these tools into telemedicine infrastructure.

Prospero registration: CRD42022355460.

导言:可穿戴设备和远程医疗被越来越多地用于跟踪患者群体的健康相关参数。由于步态和姿势控制缺陷是运动障碍和多发性硬化症患者行动不便的原因之一,我们认为对远程医疗中用于监测这类患者步态和姿势的设备进行评估很有意义:为了进行这项系统性研究,我们检索了 MEDLINE (PubMed)、SCOPUS、Cochrane Library 和 SPORTDiscus 等电子数据库。在检索到的 452 条记录中,有 12 条符合纳入/排除标准。检索了有关(1)研究特点和临床方面、(2)技术、(3)远程监控和远程咨询的数据,并对研究进行了质量评估:所有研究均涉及帕金森病患者;大多数研究使用三轴加速度计进行一般评估(4 项)、运动波动评估(3 项)、跌倒评估(2 项)和转身评估(3 项)。不同研究的传感器位置和数量差异很大。九项研究使用实验室验证的算法进行数据分析。只有一项研究讨论了同步患者反馈和异步远程会诊:可穿戴设备能够对患者进行真实世界的监测,并提出与潜在步态障碍相关的症状和行为的生物标志物,从而丰富临床评估和个性化治疗方案。随着数字医疗的发展,需要进一步开展研究,以提高设备的准确性,评估用户的可接受性,并将这些工具整合到远程医疗基础设施中。
{"title":"Wearable devices for gait and posture monitoring via telemedicine in people with movement disorders and multiple sclerosis: a systematic review.","authors":"Francesca Salaorni, Giulia Bonardi, Federico Schena, Michele Tinazzi, Marialuisa Gandolfi","doi":"10.1080/17434440.2023.2298342","DOIUrl":"10.1080/17434440.2023.2298342","url":null,"abstract":"<p><strong>Introduction: </strong>Wearable devices and telemedicine are increasingly used to track health-related parameters across patient populations. Since gait and postural control deficits contribute to mobility deficits in persons with movement disorders and multiple sclerosis, we thought it interesting to evaluate devices in telemedicine for gait and posture monitoring in such patients.</p><p><strong>Methods: </strong>For this systematic review, we searched the electronic databases MEDLINE (PubMed), SCOPUS, Cochrane Library, and SPORTDiscus. Of the 452 records retrieved, 12 met the inclusion/exclusion criteria. Data about (1) study characteristics and clinical aspects, (2) technical, and (3) telemonitoring and teleconsulting were retrieved, The studies were quality assessed.</p><p><strong>Results: </strong>All studies involved patients with Parkinson's disease; most used triaxial accelerometers for general assessment (<i>n</i> = 4), assessment of motor fluctuation (<i>n</i> = 3), falls (<i>n</i> = 2), and turning (<i>n</i> = 3). Sensor placement and count varied widely across studies. Nine used lab-validated algorithms for data analysis. Only one discussed synchronous patient feedback and asynchronous teleconsultation.</p><p><strong>Conclusions: </strong>Wearable devices enable real-world patient monitoring and suggest biomarkers for symptoms and behaviors related to underlying gait disorders. thus enriching clinical assessment and personalized treatment plans. As digital healthcare evolves, further research is needed to enhance device accuracy, assess user acceptability, and integrate these tools into telemedicine infrastructure.</p><p><strong>Prospero registration: </strong>CRD42022355460.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138833699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The current use of tissue expanders in breast reconstruction: device design, features, and technical considerations. 组织扩张器在乳房重建中的当前应用:设备设计、特点和技术考虑。
Pub Date : 2024-01-01 Epub Date: 2024-02-04 DOI: 10.1080/17434440.2023.2288911
Min-Jeong Cho, Rana V Farhadi, David W Nash, Joseph Kaleeny, Stephen P Povoski, Albert H Chao

Introduction: The use of tissue expanders (TE) in post-mastectomy breast reconstruction is a widely accepted practice, especially in patients desiring implant-based breast reconstruction. It has become the standard of care to perform a two-staged breast reconstruction using tissue expanders for the past 50 years due to its reliability, safety, cost-effectiveness, and versatility. Due to its popularity, there are numerous types and features of breast tissue expanders and various surgical approaches available for plastic surgeons.

Areas covered: In this article, we will review the role of tissue expanders in breast reconstruction, the types and features of breast tissue expanders, and technical considerations.

Expert opinion: The use of tissue expanders in breast reconstruction offers significant advantages of preserving the breast skin envelope and reestablishing the breast mound. With evolving approaches to breast reconstruction, tissue expander design, and application underwent several refinements and modifications. Due to these advances, studies on its long-term efficacy and safety profile typically fall behind and more studies with higher levels of evidence are needed to better evaluate the efficacy and safety profile of tissue expanders. With increased understanding, reconstructive surgeons can minimize complications and maximize reconstructive, aesthetic outcomes with high patient satisfaction.

在乳房切除术后乳房重建中使用组织扩张器(TE)是一种被广泛接受的做法,特别是在希望以植入物为基础的乳房重建的患者中。在过去的50年里,由于其可靠性、安全性、成本效益和通用性,使用组织扩张器进行两阶段乳房重建已经成为标准的护理方法。由于它的普及,有许多类型和特点的乳房组织扩张器和各种手术方法可用于整形外科医生。涉及领域:在这篇文章中,我们将回顾组织扩张器在乳房重建中的作用,乳房组织扩张器的类型和特点,以及技术上的考虑。专家意见:在乳房重建中使用组织扩张器在保留乳房皮肤包膜和重建乳房丘方面具有显著的优势。随着乳房重建方法的发展,组织扩张器的设计和应用经历了几次改进和修改。由于这些进展,对其长期疗效和安全性的研究通常落后,需要更多的研究和更高水平的证据来更好地评估组织扩张剂的疗效和安全性。随着了解的增加,重建外科医生可以最大限度地减少并发症,最大限度地提高重建,美观的结果,患者满意度高。
{"title":"The current use of tissue expanders in breast reconstruction: device design, features, and technical considerations.","authors":"Min-Jeong Cho, Rana V Farhadi, David W Nash, Joseph Kaleeny, Stephen P Povoski, Albert H Chao","doi":"10.1080/17434440.2023.2288911","DOIUrl":"10.1080/17434440.2023.2288911","url":null,"abstract":"<p><strong>Introduction: </strong>The use of tissue expanders (TE) in post-mastectomy breast reconstruction is a widely accepted practice, especially in patients desiring implant-based breast reconstruction. It has become the standard of care to perform a two-staged breast reconstruction using tissue expanders for the past 50 years due to its reliability, safety, cost-effectiveness, and versatility. Due to its popularity, there are numerous types and features of breast tissue expanders and various surgical approaches available for plastic surgeons.</p><p><strong>Areas covered: </strong>In this article, we will review the role of tissue expanders in breast reconstruction, the types and features of breast tissue expanders, and technical considerations.</p><p><strong>Expert opinion: </strong>The use of tissue expanders in breast reconstruction offers significant advantages of preserving the breast skin envelope and reestablishing the breast mound. With evolving approaches to breast reconstruction, tissue expander design, and application underwent several refinements and modifications. Due to these advances, studies on its long-term efficacy and safety profile typically fall behind and more studies with higher levels of evidence are needed to better evaluate the efficacy and safety profile of tissue expanders. With increased understanding, reconstructive surgeons can minimize complications and maximize reconstructive, aesthetic outcomes with high patient satisfaction.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of the carpal tunnel and associated neural structures with superb microvascular imaging: a scoping review. 评价腕管及相关神经结构与精湛的微血管成像:一个范围审查。
Pub Date : 2024-01-01 Epub Date: 2024-02-04 DOI: 10.1080/17434440.2023.2285856
Ting-Yu Lin, Peng-Chieh Shen, Ke-Vin Chang, Wei-Ting Wu, Levent Özçakar

Introduction: Superb microvascular imaging (SMI) is an advanced ultrasound technique that portrays microcirculation. Its clinical applications have been studied in various diseases, including carpal tunnel syndrome (CTS) i.e. the most common entrapment neuropathy. This scoping review explores the role of SMI in diagnosing CTS or the assessment of relevant neural structures.

Methods: We conducted a comprehensive search of electronic databases (PubMed, Embase and Web of Science) up to 26 September 2023. Two independent authors conducted the literature search, quality assessment, and data extraction.

Results: This review includes seven studies comprising 385 wrists. SMI consistently revealed increased intraneural vascularity in the median nerves of patients with CTS compared to healthy individuals. While SMI demonstrated higher sensitivity than traditional Doppler methods for detecting CTS, its specificity was somewhat lower. Combining SMI with B-mode ultrasound appears to enhance the diagnostic accuracy for CTS. However, the relationship between SMI findings and CTS severity remains unclear.

Conclusions: This review highlighted the ability of SMI to provide detailed vascular structures in both healthy wrists and those with CTS. Additional research is crucial to determine the typical SMI findings of the carpal tunnel and within that context, tailor more precise diagnostic/therapeutic applications for the CTS population.

简介:高超微血管成像(SMI)是一种描绘微循环的先进超声技术。其临床应用已被研究在各种疾病,包括腕管综合征(CTS),即最常见的卡压神经病变。这篇综述探讨了SMI在诊断CTS或评估相关神经结构中的作用。方法:我们对截至2023年9月26日的PubMed、Embase和Web of Science电子数据库进行了全面检索。两位独立作者进行了文献检索、质量评估和数据提取。结果:本综述包括7项研究,涉及385个手腕。SMI一致显示,与健康个体相比,CTS患者正中神经的神经内血管增多。虽然SMI检测CTS的灵敏度高于传统的多普勒方法,但其特异性略低。SMI联合b超可提高CTS的诊断准确性。然而,重度精神分裂症的发现与CTS严重程度之间的关系尚不清楚。结论:本综述强调了SMI在健康手腕和CTS患者中提供详细血管结构的能力。进一步的研究对于确定腕管的典型SMI表现至关重要,并在此背景下为CTS人群量身定制更精确的诊断/治疗应用。
{"title":"Assessment of the carpal tunnel and associated neural structures with superb microvascular imaging: a scoping review.","authors":"Ting-Yu Lin, Peng-Chieh Shen, Ke-Vin Chang, Wei-Ting Wu, Levent Özçakar","doi":"10.1080/17434440.2023.2285856","DOIUrl":"10.1080/17434440.2023.2285856","url":null,"abstract":"<p><strong>Introduction: </strong>Superb microvascular imaging (SMI) is an advanced ultrasound technique that portrays microcirculation. Its clinical applications have been studied in various diseases, including carpal tunnel syndrome (CTS) i.e. the most common entrapment neuropathy. This scoping review explores the role of SMI in diagnosing CTS or the assessment of relevant neural structures.</p><p><strong>Methods: </strong>We conducted a comprehensive search of electronic databases (PubMed, Embase and Web of Science) up to 26 September 2023. Two independent authors conducted the literature search, quality assessment, and data extraction.</p><p><strong>Results: </strong>This review includes seven studies comprising 385 wrists. SMI consistently revealed increased intraneural vascularity in the median nerves of patients with CTS compared to healthy individuals. While SMI demonstrated higher sensitivity than traditional Doppler methods for detecting CTS, its specificity was somewhat lower. Combining SMI with B-mode ultrasound appears to enhance the diagnostic accuracy for CTS. However, the relationship between SMI findings and CTS severity remains unclear.</p><p><strong>Conclusions: </strong>This review highlighted the ability of SMI to provide detailed vascular structures in both healthy wrists and those with CTS. Additional research is crucial to determine the typical SMI findings of the carpal tunnel and within that context, tailor more precise diagnostic/therapeutic applications for the CTS population.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136400811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Technology assistance in primary total knee replacement: hype or hope? 初级全膝关节置换术的技术援助:炒作还是希望?
Pub Date : 2024-01-01 Epub Date: 2024-02-04 DOI: 10.1080/17434440.2023.2287576
Bart G Pijls

Introduction: Total knee replacement (TKR) reduces pain, it increases quality of life and it generally lasts a long time with revision rates of less than 5% at 10 years. Some authors have suggested that outcomes may be further improved by technology assistance.

Areas covered: Technology assistance in primary TKR includes technologies such as navigated TKR, patient specific instrumentation TKR and robotic TKR.

Expert opinion: In general, technology assistance results in higher accuracy of component positioning and alignment, but this is likely not clinically relevant as no clinically important difference in clinical outcomes, quality of life and complications such as revisions has been demonstrated in meta-analyses of randomized controlled trials. As technology assistance in primary TKR is increasingly used to capture patient and surgeon data, surgeons have an increasingly important role in protecting their patients' data and their own data. Real world evidence of implant registries has shown that TKR without technologically assistance can achieve perfectly acceptable outcomes. Although there is a genuine hope that technology-assisted TKR may further improve these outcomes, this hope is based on promises rather than solid evidence. At the same time, technology assisted TKR is heavily promoted including direct patient marketing, which are aspects of a hype.

全膝关节置换术(TKR)减轻疼痛,提高生活质量,通常持续时间长,10年翻修率低于5%。一些作者建议,技术援助可能会进一步改善结果。主要TKR的技术援助包括导航TKR、患者专用仪器TKR和机器人TKR等技术。专家意见:一般情况下,技术援助可以提高组件定位和对齐的准确性,但这可能与临床无关,因为随机对照试验的荟萃分析表明,在临床结果、生活质量和并发症(如修复)方面没有临床重要差异。随着初级TKR的技术援助越来越多地用于获取患者和外科医生的数据,外科医生在保护患者数据和自己的数据方面发挥着越来越重要的作用。植入物登记的真实世界证据表明,没有技术援助的TKR可以达到完全可接受的结果。虽然人们确实希望技术辅助的TKR可以进一步改善这些结果,但这种希望是基于承诺而不是确凿的证据。与此同时,技术辅助的TKR得到了大力推广,包括直接的患者营销,这是炒作的一个方面。
{"title":"Technology assistance in primary total knee replacement: hype or hope?","authors":"Bart G Pijls","doi":"10.1080/17434440.2023.2287576","DOIUrl":"10.1080/17434440.2023.2287576","url":null,"abstract":"<p><strong>Introduction: </strong>Total knee replacement (TKR) reduces pain, it increases quality of life and it generally lasts a long time with revision rates of less than 5% at 10 years. Some authors have suggested that outcomes may be further improved by technology assistance.</p><p><strong>Areas covered: </strong>Technology assistance in primary TKR includes technologies such as navigated TKR, patient specific instrumentation TKR and robotic TKR.</p><p><strong>Expert opinion: </strong>In general, technology assistance results in higher accuracy of component positioning and alignment, but this is likely not clinically relevant as no clinically important difference in clinical outcomes, quality of life and complications such as revisions has been demonstrated in meta-analyses of randomized controlled trials. As technology assistance in primary TKR is increasingly used to capture patient and surgeon data, surgeons have an increasingly important role in protecting their patients' data and their own data. Real world evidence of implant registries has shown that TKR without technologically assistance can achieve perfectly acceptable outcomes. Although there is a genuine hope that technology-assisted TKR may further improve these outcomes, this hope is based on promises rather than solid evidence. At the same time, technology assisted TKR is heavily promoted including direct patient marketing, which are aspects of a hype.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138296840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcatheter aortic valve durability, predictors of bioprosthetic valve dysfunction, longer-term outcomes - a review. 经导管主动脉瓣耐久性,生物瓣膜功能障碍的预测因素,长期结果综述。
Pub Date : 2024-01-01 Epub Date: 2024-02-04 DOI: 10.1080/17434440.2023.2288275
Abigail Johanna Šolc, Hana Línková, Petr Toušek

Introduction: Transcatheter aortic valve implantation (TAVI) is one of the most significant inventions in cardiology, as it provides a viable minimally invasive treatment option for patients with aortic stenosis, the most common valvular disease in the developed world and one with a poor prognosis when left untreated. Using data available to date, this review aims to discuss and identify possible predictors of TAVI valve durability - an essential requirement for the device's wide-spread use, especially in younger patients.

Areas covered: This article explores the main causes of bioprosthetic valve dysfunction (BVD) based on pathophysiology and available data, and reviews possible predictors of BVD including prosthesis-related, procedure-related, and patient-related factors. An emphasis is made on affectable predictors, which could potentially be targeted with prevention management and improve valve durability. A literature search of online medical databases was conducted using relevant key words and dates; significant clinical trials were identified. A brief overview of important randomized controlled trials with mid to long-term follow-up is included in this article.

Expert opinion: Identifying modifiable predictors of valve dysfunction presents an opportunity to enhance and predict valve durability - a necessity as patients with longer life-expectancies are being considered for the procedure.

导读:经导管主动脉瓣植入术(TAVI)是心脏病学中最重要的发明之一,因为它为主动脉瓣狭窄患者提供了一种可行的微创治疗选择。主动脉瓣狭窄是发达国家最常见的瓣膜疾病,如果不及时治疗,预后很差。利用迄今为止的数据,本综述旨在讨论和确定TAVI瓣膜耐久性的可能预测因素——这是该设备广泛使用的基本要求,特别是在年轻患者中。涵盖领域:本文基于病理生理学和现有数据探讨了生物假体瓣膜功能障碍(BVD)的主要原因,并综述了BVD的可能预测因素,包括假体相关因素、手术相关因素和患者相关因素。重点放在可影响的预测指标上,这些指标有可能成为预防管理的目标,并提高阀门的耐用性。使用相关关键词和日期对在线医学数据库进行文献检索;确定了有意义的临床试验。本文简要概述了具有中长期随访的重要随机对照试验。专家意见:确定可修改的瓣膜功能障碍预测因子为增强和预测瓣膜耐久性提供了机会——这是必要的,因为预期寿命较长的患者正在考虑进行该手术。
{"title":"Transcatheter aortic valve durability, predictors of bioprosthetic valve dysfunction, longer-term outcomes - a review.","authors":"Abigail Johanna Šolc, Hana Línková, Petr Toušek","doi":"10.1080/17434440.2023.2288275","DOIUrl":"10.1080/17434440.2023.2288275","url":null,"abstract":"<p><strong>Introduction: </strong>Transcatheter aortic valve implantation (TAVI) is one of the most significant inventions in cardiology, as it provides a viable minimally invasive treatment option for patients with aortic stenosis, the most common valvular disease in the developed world and one with a poor prognosis when left untreated. Using data available to date, this review aims to discuss and identify possible predictors of TAVI valve durability - an essential requirement for the device's wide-spread use, especially in younger patients.</p><p><strong>Areas covered: </strong>This article explores the main causes of bioprosthetic valve dysfunction (BVD) based on pathophysiology and available data, and reviews possible predictors of BVD including prosthesis-related, procedure-related, and patient-related factors. An emphasis is made on affectable predictors, which could potentially be targeted with prevention management and improve valve durability. A literature search of online medical databases was conducted using relevant key words and dates; significant clinical trials were identified. A brief overview of important randomized controlled trials with mid to long-term follow-up is included in this article.</p><p><strong>Expert opinion: </strong>Identifying modifiable predictors of valve dysfunction presents an opportunity to enhance and predict valve durability - a necessity as patients with longer life-expectancies are being considered for the procedure.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138465158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Devices for osteoarthritis symptoms treatment: a patent review. 骨关节炎症状治疗设备:专利回顾。
Pub Date : 2024-01-01 Epub Date: 2024-02-04 DOI: 10.1080/17434440.2023.2298729
Mariana Mendonça Santos, Anamaria Mendonça Santos, José Adão Carvalho Nascimento, Cláudio Carvalho Santana, Ana Maria Santos Oliveira, Silvia Vitoria Silva Cezar, Alcimary Bispo Santos, Luiza Abrahão Frank, Mairim Russo Serafini

Introduction: Osteoarthritis is a musculoskeletal disease that can lead to the loss and inability of those affected to perform normal daily functions, which leads to a decrease in quality of life. The main symptoms of osteoarthritis are tenderness, joint pain, stiffness, crepitus, limited movement, and local inflammation.

Areas covered: The selected patents were deposited from 2010 to April 2022 involving 57 documents that were in line with the study objective in the final selection. The patents were classified in years, country, and applicants. Also, the therapeutic fields that presented the most documents were electrical stimulation, phototherapy, and ultrasound, followed by magnetic, electromagnetic, and thermotherapy. Therefore, the most current therapies used in the documents are already on the market.

Expert opinion: Although the OA is cureless, non-surgical treatments are classified as the primary management approach for this disease. The pharmacological and non-pharmacological therapies are employed to reduce its prevalence and ensure the effectiveness of treatments. A strategy for relieving OA symptoms is non-pharmacological treatment, which can be based on exercise and patient education, combined with other alternative therapies. These therapies are used as supplements to the main OA treatments, enhancing the effectiveness of treatment outcomes.

导言:骨关节炎是一种肌肉骨骼疾病,可导致患者丧失和无法行使正常的日常功能,从而降低生活质量。骨关节炎的主要症状是触痛、关节疼痛、僵硬、吱吱作响、活动受限和局部发炎:所选专利的交存时间为 2010 年至 2022 年 4 月,涉及 57 份最终选定的符合研究目标的文件。这些专利按年份、国家和申请人进行了分类。此外,文献最多的治疗领域是电刺激、光疗和超声波,其次是磁疗、电磁疗法和热疗。因此,这些文献中使用的最新疗法已经在市场上出现:专家意见:虽然 OA 无法治愈,但非手术疗法被列为该疾病的主要治疗方法。采用药物和非药物疗法是为了降低其发病率并确保治疗效果。非药物治疗是缓解 OA 症状的一种策略,它可以以运动和患者教育为基础,并结合其他替代疗法。这些疗法可作为 OA 主要治疗方法的补充,提高治疗效果。
{"title":"Devices for osteoarthritis symptoms treatment: a patent review.","authors":"Mariana Mendonça Santos, Anamaria Mendonça Santos, José Adão Carvalho Nascimento, Cláudio Carvalho Santana, Ana Maria Santos Oliveira, Silvia Vitoria Silva Cezar, Alcimary Bispo Santos, Luiza Abrahão Frank, Mairim Russo Serafini","doi":"10.1080/17434440.2023.2298729","DOIUrl":"10.1080/17434440.2023.2298729","url":null,"abstract":"<p><strong>Introduction: </strong>Osteoarthritis is a musculoskeletal disease that can lead to the loss and inability of those affected to perform normal daily functions, which leads to a decrease in quality of life. The main symptoms of osteoarthritis are tenderness, joint pain, stiffness, crepitus, limited movement, and local inflammation.</p><p><strong>Areas covered: </strong>The selected patents were deposited from 2010 to April 2022 involving 57 documents that were in line with the study objective in the final selection. The patents were classified in years, country, and applicants. Also, the therapeutic fields that presented the most documents were electrical stimulation, phototherapy, and ultrasound, followed by magnetic, electromagnetic, and thermotherapy. Therefore, the most current therapies used in the documents are already on the market.</p><p><strong>Expert opinion: </strong>Although the OA is cureless, non-surgical treatments are classified as the primary management approach for this disease. The pharmacological and non-pharmacological therapies are employed to reduce its prevalence and ensure the effectiveness of treatments. A strategy for relieving OA symptoms is non-pharmacological treatment, which can be based on exercise and patient education, combined with other alternative therapies. These therapies are used as supplements to the main OA treatments, enhancing the effectiveness of treatment outcomes.</p>","PeriodicalId":94006,"journal":{"name":"Expert review of medical devices","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139379033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Expert review of medical devices
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1